(CRM) Salesforce.com - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US79466L3024
CRM Platform, Agentforce, Data Cloud, Slack, Tableau
Dividends
| Dividend Yield | 0.63% |
| Yield on Cost 5y | 0.75% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 14.4% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 32.6% |
| Value at Risk 5%th | 49.6% |
| Relative Tail Risk | -7.50% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.02 |
| Alpha | -41.24 |
| CAGR/Max DD | 0.68 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.558 |
| Beta | 0.999 |
| Beta Downside | 1.072 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.37% |
| Mean DD | 13.64% |
| Median DD | 10.95% |
Description: CRM Salesforce.com December 01, 2025
Salesforce (CRM) is a global provider of customer relationship management (CRM) software that links companies with their customers across sales, service, marketing, commerce, and analytics. Its product suite now includes Agentforce (an AI-driven agent layer), Data Cloud (a unified data engine), industry-specific AI agents, Salesforce Starter for SMBs, Slack for workplace collaboration, Tableau for end-to-end analytics, and a suite of field-service and commerce solutions. Strategic partnerships, notably with Google Workspace, embed Agentforce 360 and the emerging Salesforce Gemini AI across sales and IT workflows.
Key recent metrics: FY2024 revenue reached $27.1 billion, up ~15% YoY, with subscription and support revenue comprising roughly 90% of total-a sign of high-margin, recurring cash flow. The broader CRM software market is expanding at a ~12% CAGR, driven by accelerating digital transformation and enterprise AI adoption, which underpins Salesforce’s growth outlook. Additionally, the company’s AI-centric initiatives (Gemini, Agentforce) have begun to lift average contract values by an estimated 8% YoY, reflecting premium pricing for AI-enhanced capabilities.
For a deeper, data-driven valuation perspective, you might explore the detailed metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (7.22b TTM) > 0 and > 6% of Revenue (6% = 2.42b TTM) |
| FCFTA 0.14 (>2.0%) and ΔFCFTA 0.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -0.86% (prev 5.51%; Δ -6.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 13.50b > Net Income 7.22b (YES >=105%, WARN >=100%) |
| Net Debt (2.16b) to EBITDA (11.97b) ratio: 0.18 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (962.0m) change vs 12m ago -1.33% (target <= -2.0% for YES) |
| Gross Margin 77.73% (prev 76.94%; Δ 0.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 43.23% (prev 40.69%; Δ 2.54pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 63.59 (EBITDA TTM 11.97b / Interest Expense TTM 135.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.93
| (A) -0.00 = (Total Current Assets 21.06b - Total Current Liabilities 21.41b) / Total Assets 95.14b |
| (B) 0.22 = Retained Earnings (Balance) 20.67b / Total Assets 95.14b |
| (C) 0.09 = EBIT TTM 8.58b / Avg Total Assets 93.27b |
| (D) 0.59 = Book Value of Equity 20.83b / Total Liabilities 35.12b |
| Total Rating: 1.93 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 81.87
| 1. Piotroski 7.50pt |
| 2. FCF Yield 5.12% |
| 3. FCF Margin 31.98% |
| 4. Debt/Equity 0.19 |
| 5. Debt/Ebitda 0.18 |
| 6. ROIC - WACC (= 0.99)% |
| 7. RoE 11.88% |
| 8. Rev. Trend 98.60% |
| 9. EPS Trend 94.69% |
What is the price of CRM shares?
As of December 16, 2025, the stock is trading at USD 254.58 with a total of 10,236,310 shares traded.
Over the past week, the price has changed by +1.04%, over one month by +7.62%, over three months by +8.32% and over the past year by -26.15%.
Over the past week, the price has changed by +1.04%, over one month by +7.62%, over three months by +8.32% and over the past year by -26.15%.
Is CRM a buy, sell or hold?
Salesforce.com has received a consensus analysts rating of 4.22.
Therefore, it is recommended to buy CRM.
- Strong Buy: 28
- Buy: 13
- Hold: 12
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the CRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 328 | 28.8% |
| Analysts Target Price | 328 | 28.8% |
| ValueRay Target Price | 278.5 | 9.4% |
CRM Fundamental Data Overview December 13, 2025
Market Cap USD = 249.76b (249.76b USD * 1.0 USD.USD)
P/E Trailing = 35.3571
P/E Forward = 20.3666
P/S = 6.1948
P/B = 4.1245
P/EG = 1.2299
Beta = 1.253
Revenue TTM = 40.32b USD
EBIT TTM = 8.58b USD
EBITDA TTM = 11.97b USD
Long Term Debt = 8.44b USD (from longTermDebt, last quarter)
Short Term Debt = 564.0m USD (from shortTermDebt, last quarter)
Debt = 11.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.16b USD (from netDebt column, last quarter)
Enterprise Value = 251.92b USD (249.76b + Debt 11.14b - CCE 8.98b)
Interest Coverage Ratio = 63.59 (Ebit TTM 8.58b / Interest Expense TTM 135.0m)
FCF Yield = 5.12% (FCF TTM 12.89b / Enterprise Value 251.92b)
FCF Margin = 31.98% (FCF TTM 12.89b / Revenue TTM 40.32b)
Net Margin = 17.91% (Net Income TTM 7.22b / Revenue TTM 40.32b)
Gross Margin = 77.73% ((Revenue TTM 40.32b - Cost of Revenue TTM 8.98b) / Revenue TTM)
Gross Margin QoQ = 78.02% (prev 78.10%)
Tobins Q-Ratio = 2.65 (Enterprise Value 251.92b / Total Assets 95.14b)
Interest Expense / Debt = 0.60% (Interest Expense 67.0m / Debt 11.14b)
Taxrate = 16.96% (426.0m / 2.51b)
NOPAT = 7.13b (EBIT 8.58b * (1 - 16.96%))
Current Ratio = 0.98 (Total Current Assets 21.06b / Total Current Liabilities 21.41b)
Debt / Equity = 0.19 (Debt 11.14b / totalStockholderEquity, last quarter 60.02b)
Debt / EBITDA = 0.18 (Net Debt 2.16b / EBITDA 11.97b)
Debt / FCF = 0.17 (Net Debt 2.16b / FCF TTM 12.89b)
Total Stockholder Equity = 60.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.59% (Net Income 7.22b / Total Assets 95.14b)
RoE = 11.88% (Net Income TTM 7.22b / Total Stockholder Equity 60.80b)
RoCE = 12.40% (EBIT 8.58b / Capital Employed (Equity 60.80b + L.T.Debt 8.44b))
RoIC = 10.30% (NOPAT 7.13b / Invested Capital 69.23b)
WACC = 9.31% (E(249.76b)/V(260.90b) * Re(9.70%) + D(11.14b)/V(260.90b) * Rd(0.60%) * (1-Tc(0.17)))
Discount Rate = 9.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
[DCF Debug] Terminal Value 76.25% ; FCFE base≈12.49b ; Y1≈15.40b ; Y5≈26.28b
Fair Price DCF = 356.0 (DCF Value 333.54b / Shares Outstanding 937.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 94.69 | EPS CAGR: 43.45% | SUE: 4.0 | # QB: 2
Revenue Correlation: 98.60 | Revenue CAGR: 9.39% | SUE: -0.22 | # QB: 0
EPS next Quarter (2026-04-30): EPS=3.01 | Chg30d=+0.078 | Revisions Net=+25 | Analysts=40
EPS next Year (2027-01-31): EPS=13.05 | Chg30d=+0.348 | Revisions Net=+36 | Growth EPS=+10.9% | Growth Revenue=+10.7%
P/E Trailing = 35.3571
P/E Forward = 20.3666
P/S = 6.1948
P/B = 4.1245
P/EG = 1.2299
Beta = 1.253
Revenue TTM = 40.32b USD
EBIT TTM = 8.58b USD
EBITDA TTM = 11.97b USD
Long Term Debt = 8.44b USD (from longTermDebt, last quarter)
Short Term Debt = 564.0m USD (from shortTermDebt, last quarter)
Debt = 11.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.16b USD (from netDebt column, last quarter)
Enterprise Value = 251.92b USD (249.76b + Debt 11.14b - CCE 8.98b)
Interest Coverage Ratio = 63.59 (Ebit TTM 8.58b / Interest Expense TTM 135.0m)
FCF Yield = 5.12% (FCF TTM 12.89b / Enterprise Value 251.92b)
FCF Margin = 31.98% (FCF TTM 12.89b / Revenue TTM 40.32b)
Net Margin = 17.91% (Net Income TTM 7.22b / Revenue TTM 40.32b)
Gross Margin = 77.73% ((Revenue TTM 40.32b - Cost of Revenue TTM 8.98b) / Revenue TTM)
Gross Margin QoQ = 78.02% (prev 78.10%)
Tobins Q-Ratio = 2.65 (Enterprise Value 251.92b / Total Assets 95.14b)
Interest Expense / Debt = 0.60% (Interest Expense 67.0m / Debt 11.14b)
Taxrate = 16.96% (426.0m / 2.51b)
NOPAT = 7.13b (EBIT 8.58b * (1 - 16.96%))
Current Ratio = 0.98 (Total Current Assets 21.06b / Total Current Liabilities 21.41b)
Debt / Equity = 0.19 (Debt 11.14b / totalStockholderEquity, last quarter 60.02b)
Debt / EBITDA = 0.18 (Net Debt 2.16b / EBITDA 11.97b)
Debt / FCF = 0.17 (Net Debt 2.16b / FCF TTM 12.89b)
Total Stockholder Equity = 60.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.59% (Net Income 7.22b / Total Assets 95.14b)
RoE = 11.88% (Net Income TTM 7.22b / Total Stockholder Equity 60.80b)
RoCE = 12.40% (EBIT 8.58b / Capital Employed (Equity 60.80b + L.T.Debt 8.44b))
RoIC = 10.30% (NOPAT 7.13b / Invested Capital 69.23b)
WACC = 9.31% (E(249.76b)/V(260.90b) * Re(9.70%) + D(11.14b)/V(260.90b) * Rd(0.60%) * (1-Tc(0.17)))
Discount Rate = 9.70% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
[DCF Debug] Terminal Value 76.25% ; FCFE base≈12.49b ; Y1≈15.40b ; Y5≈26.28b
Fair Price DCF = 356.0 (DCF Value 333.54b / Shares Outstanding 937.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 94.69 | EPS CAGR: 43.45% | SUE: 4.0 | # QB: 2
Revenue Correlation: 98.60 | Revenue CAGR: 9.39% | SUE: -0.22 | # QB: 0
EPS next Quarter (2026-04-30): EPS=3.01 | Chg30d=+0.078 | Revisions Net=+25 | Analysts=40
EPS next Year (2027-01-31): EPS=13.05 | Chg30d=+0.348 | Revisions Net=+36 | Growth EPS=+10.9% | Growth Revenue=+10.7%
Additional Sources for CRM Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle